Blaze Systems Frequently Asked Questions (FAQ)
When was Blaze Systems founded?
Blaze Systems was founded in 1991.
Where is Blaze Systems's headquarters?
Blaze Systems's headquarters is located at 300 Creek View Road, Suite 204, Newark.
What is Blaze Systems's latest funding round?
Blaze Systems's latest funding round is Incubator/Accelerator.
Who are the investors of Blaze Systems?
Investors of Blaze Systems include Delaware Technology Park.
Who are Blaze Systems's competitors?
Competitors of Blaze Systems include Clinipace, Bloomage BioTech, Finesse Solutions, CMC Biologics, ReSearch Pharmaceutical Services and 12 more.
Compare Blaze Systems to Competitors
The company provide business development services to clients in the pharmaceutical, biotechnology, consumer health, and drug delivery industries worldwide. The company's team members represent an array of nationalities and a mix of commercial, manufacturing, medical, and scientific expertise, gained from decades of experience with both global pharmaceutical and development-stage companies
Integrated Biosystems (Napa, CA) is the world's leading supplier of controlled freeze and thaw technologies for storage and transport of specialized biopharmaceuticals. Integrated Biosystems, Inc. was acquired by Stedim S.A. (Euronext Paris: DIM).
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
MOgene is a biotechnology company, focused on understanding the mechanisms of cellular and organismal toxicity of chemical compounds and applying the knowledge to improve safety and efficacy of products across life science industries. MOgene uses a systems biology approach to understand gene function in the context of biological networks, to develop assays and biomarkers for molecular diagnostic solutions that would help address toxicity issues. MOgene is an Agilent-certified gene expression service provider and aims to provide microarray services including custom design of arrays, experiment design and detailed bioinformatics analysis.
AthenaES specializes in the development and commercialization of advanced biotechnology-based products. Throughout its eleven year history, the company has maintained a broad perspective for applying its core competency, the use of proteins and enzymes for commercial applications, to develop products. As such, the company currently markets its products and services through two business units and maintains an exploratory R&D group. The Athena Enzyme Systems Group aims to provide specialty reagents and proteins for the production and recovery of recombinant proteins along with providing contract R&D services. Products include: Expression Media, Serum-free Media, Protein Refolding kits, and the PDQ Protease Assay. This business unit also aims to provide specialized contract research, development and manufacturing services for the production of recombinant proteins. The Athena Environmental Services Group designs, develops and manufactures environmentally responsible products. Products developed include: The Bilge Pill, a biodegradable cleaning product for the removal of oil in boat bilges, and a plant nutrient supplement used in hydroponics, hobby gardens and horticulture that replaces conventional fertilizers, and the Sting Thing, an enzyme-based invertebrate sting treatment product. More recently, this group developed and has introduced a water-soluble, reversible glue, MagiGlue. The Athena Exploratory Science Group has the mission to pursue research with the potential for commercial, environmental and social impact. These projects are far reaching in their scope and represent high risk, high-value projects.
Spreading innovation in the Nano- and Biotechnology fields - this is the aim of Tethis. The company are heading for this goal through a tri-fold market approach reflected by the three business units of Tethis: Tethis Systems, Tethis Technology Services and Tethis Research. Tethis Systems focuses on the design and sale of nanoparticle synthesis and nanocoating units allowing customers to develop their own nanotech-products in-house. Tethis Technology Services supports customers with nano - and biotech product development by technical consulting and by opening Tethis' platform technologies for services such as tailor-made coatings or nanopowder development. Tethis Research targets on the incorporation of nanotechnology in devices, for instance by the integration of nanotechnology, biotechnology and microfabrication. Many of the company's research projects are based on collaborations with industries, universities and research centers reflecting the company's motto "Integration through collaboration".n